Previous studies have reported substantial involvement of the noradrenergic system in
Parkinson’s disease. Neuromelanin-sensitive MRI sequences and PET tracers have become …

Degeneration of noradrenergic neurons may underlie the disabling nonmotor symptoms in
patients with Parkinson disease (PD). Quantification of the loss of noradrenergic neurons by …

… ± 39.5s, p < 0.001), despite similar duration for A and B phases between groups. This
points to inclusion of less A and B phases in each CAP in PD patients. Accordingly, index of A …

Noradrenergic neurotransmission may play an important role in tremor modulation through
its innervation of key structures of the central tremor circuits. Here, Parkinson's disease (PD) …

Objectives This study aimed to assess if, during the second wave of the COVID-19 pandemic,
healthcare workers had increased severe acute respiratory syndrome coronavirus 2 (SARS…

Parkinson’s disease (PD) is a neurodegenerative disorder, well-known for its motor
symptoms; however, it also adversely affects cognitive functions, including language, a highly …

Noradrenergic neurons in both the peripheral nervous system and in the central nervous
system (CNS) undergo severe degeneration in patients with Parkinson's disease (PD). This …

Objectives To assess if healthcare workers during the second wave of the COVID-19
pandemic had increased SARS-CoV-2 infection rates following close contact with patients, co-…

Objectives To assess if healthcare workers during the second wave of the coronavirus
disease 2019 (COVID-19) pandemic had increased severe acute respiratory syndrome …

Objectives: To assess if healthcare workers during the second wave of the COVID-19
pandemic had increased SARS-CoV-2 infection rates following close contact with patients, co-…